Pituitary and testicular function studies. I. Experience with a new gonadal inhibitor, 17-alpha-pregn-4-en-20-yno-(2,3-d)isoxazol-17-ol (Danazol).
D015068:17-Ketosteroids / Q000097:blood; D000328:Adult; D000728:Androgens / Q000096:biosynthesis*; D000731:Androstanes / Q000097:blood; D000963:Antimetabolites / Q000494:pharmacology; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D002986:Clinical Trials as Topic; D002996:Clomiphene; D003687:Dehydroepiandrosterone / Q000097:blood; D003864:Depression, Chemical; D005246:Feedback; D005640:Follicle Stimulating Hormone / Q000652:urine; D006065:Gonadotropins, Pituitary / Q000378:metabolism*; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology; D007985:Leydig Cells / Q000187:drug effects / Q000378:metabolism*; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008875:Middle Aged; D010080:Oxazoles / Q000494:pharmacology*; D010901:Pituitary Function Tests; D010902:Pituitary Gland / Q000187:drug effects; D011278:Pregnanes / Q000494:pharmacology*; D013739:Testosterone / Q000097:blood
D015068:17-Ketosteroids; D000728:Androgens; D000731:Androstanes; D000963:Antimetabolites; D006063:Chorionic Gonadotropin; D006065:Gonadotropins, Pituitary; D010080:Oxazoles; D011278:Pregnanes; D002996:Clomiphene; D013739:Testosterone; D003687:Dehydroepiandrosterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone